Trial Details

COMPLETED
Basic Information
Clinical ID c3468
Identifier NCT02009618
Trial Title The Effects of Rifaximin Therapy in Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions IBS
Interventions DRUG: Rifaximin|DRUG: placebo
Participant Information
Sponsor Bezmialem Vakif University
City Istanbul
Country/Region Turkey (Türkiye)
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2013-01
Primary Completion Date 2013-10
Completion Date 2013-10